Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05652751

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05652751
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05652751. Randomized; triple masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2023-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
Intervention (Drug)
nerve growth factor
Intervention (Drug)
physiological saline
Intervention (Device)
EA
Intervention (Device)
sham EA
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University (class: other)

Record details

Record id
cardio:ct-nct05652751
Content hash
22a9488b9632a3386bce7d4257d28b921d99447dc7d735e62ae7d5b4fa779457